Search
01/02/2022
Detection of azole resistance in Aspergillus fumigatus complex isolates MALDI-TOF mass
Zvezdanova, ME, Arroyo, MJ, Mendez, G, Candela, A, Mancera, L, Rodriguez, JG, Serra, JL, Jimenez, R, Lozano, I, Castro, C, Lopez, C, Munoz, P, Guinea, J, Escribano, P, Rodriguez-Sanchez, B, Sánchez-Reus F.. Detection of azole resistance in Aspergillus fumigatus complex isolates MALDI-TOF mass. CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(2)DOI:10.1016/j.cmi.2021.06.005. PMID:34147673. IF:14.200(Q1/1D).
01/02/2022
MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport
Hueso, M, Grinan, R, Mallen, A, Navarro, E, Purqueras, E, Goma, M, Sbraga, F, Blasco-Lucas, A, Revilla, G, Santos, D, Canyelles, M, Julve, J, Escola-Gil, JC, Rotllan, N. MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022; 146DOI:10.1016/j.biopha.2021.112596. PMID:35062066. IF:7.500(Q1/1D).
31/01/2022
Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders
Sampedro, F, Camara, E, Kulisevsky, J. Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.843440. PMID:35173676. IF:3.400(Q2/5D).
31/01/2022
Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery
Marcucci, M, Painter, TW, Conen, D, Leslie, K, Lomivorotov, VV, Sessler, D, Chan, MTV, Borges, FK, Zapata, MJM, Wang, CY, Xavier, D, Ofori, SN, Landoni, G, Efremov, S, Kleinlugtenbelt, YV, Szczeklik, W, Schmartz, D, Garg, AX, Short, TG, Wittmann, M, Meyhoff, CS, Amir, M, Torres, D, Patel, A, Duceppe, E, Ruetzler, K, Parlow, JL, Tandon, V, Wang, MK, Fleischmann, E, Polanczyk, CA, Jayaram, R, Astrakov, SV, Rao, M, VanHelder, T, Wu, WKK, Cheong, CC, Ayad, S, Abubakirov, M, Kirov, M, Bhatt, K, de Nadal, M, Likhvantsev, V, Iglesisas, PP, Aguado, HJ, McGillion, M, Lamy, A, Whitlock, RP, Roshanov, P, Stillo, D, Copland, I, Vincent, J, Balasubramanian, K, Bangdiwala, SI, Biccard, B, Kurz, A, Srinathan, S, Petit, S, Eikelboom, J, Richards, T, Gross, PL, Alfonsi, P, Guyatt, G, Belley-Cote, E, Spence, J, McIntyre, W, Yusuf, S, Devereaux, PJ. Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery. Trials. 2022; 23(1)DOI:10.1186/s13063-021-05992-1. PMID:35101083. IF:2.500(Q3/8D).
31/01/2022
NAD plus -Increasing Strategies to Improve Cardiometabolic Health?
Blanco-Vaca, F, Rotllan, N, Canyelles, M, Mauricio, D, Escola-Gil, JC, Julve, J. NAD plus -Increasing Strategies to Improve Cardiometabolic Health?. Frontiers in Endocrinology. 2022; 12DOI:10.3389/fendo.2021.815565. PMID:35173682. IF:5.200(Q1/3D).
29/01/2022
Interim opioid agonist treatment for opioid addiction: a systematic review
Jofra, LS, Puig, T, Sola, I, Trujols, J. Interim opioid agonist treatment for opioid addiction: a systematic review. Harm Reduction Journal. 2022; 19(1)DOI:10.1186/s12954-022-00592-x. PMID:35090475. IF:4.400(Q1/2D).
29/01/2022
Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation position paper
Koller, A, Laughlin, MH, Cenko, E, de Wit, C, Toth, K, Bugiardini, R, Trifunovits, D, Vavlukis, M, Manfrini, O, Lelbach, A, Dornyei, G, Padro, T, Badimon, L, Tousoulis, D, Gielen, S, Duncker, DJ. Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation position paper. CARDIOVASCULAR RESEARCH. 2022; 118(2)DOI:10.1093/cvr/cvab246. PMID:34358290. IF:10.800(Q1/1D).
27/01/2022
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid
Gobom, J, Parnetti, L, Rosa-Neto, P, Vyhnalek, M, Gauthier, S, Cataldi, S, Lerch, O, Laczo, J, Cechova, K, Clarin, M, Benet, AI, Pascoal, TA, Rahmouni, N, Vandijck, M, Huyck, E, Le Bastard, N, Stevenson, J, Chamoun, M, Alcolea, D, Lleo, A, Andreasson, U, Verbeek, MM, Bellomo, G, Rinaldi, R, Ashton, N, Zetterberg, H, Sheardova, K, Hort, J, Blennow, K. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2022; 60(2)DOI:10.1515/cclm-2021-0651. PMID:34773730. IF:6.800(Q1/2D).